LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
LIfT BioSciences has raised $13.4M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
LIfT BioSciences's investors include MassChallenge, Innovate UK, Starbloom Capital, KIZOO Technology Capital, Lifespan Vision Ventures.
LIfT BioSciences is headquartered in London, United Kingdom.
LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy
LIfT BioSciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LIfT BioSciences — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/lift-biosciences. Accessed October 17, 2026.
VCBacked. (2024). LIfT BioSciences — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/lift-biosciences
{{cite web |title=LIfT BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/lift-biosciences |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated